These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32496438)

  • 21. The effect of carnitine supplementation in valproate-induced hyperammonaemia.
    Böhles H; Sewell AC; Wenzel D
    Acta Paediatr; 1996 Apr; 85(4):446-9. PubMed ID: 8740302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. L-carnitine supplementation in childhood epilepsy: current perspectives.
    De Vivo DC; Bohan TP; Coulter DL; Dreifuss FE; Greenwood RS; Nordli DR; Shields WD; Stafstrom CE; Tein I
    Epilepsia; 1998 Nov; 39(11):1216-25. PubMed ID: 9821988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential biomarker of fibroblast growth factor 21 in valproic acid-treated livers.
    Xu X; Guo C; Liang X; Li R; Chen J
    Biofactors; 2019 Sep; 45(5):740-749. PubMed ID: 31120577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Levocarnitine-induced hypophosphatemia in a hemodialysis patient with acute valproic acid toxicity.
    Prohaska ES; Muzyk AJ; Rivelli SK
    J Neuropsychiatry Clin Neurosci; 2012; 24(1):E18-9. PubMed ID: 22450630
    [No Abstract]   [Full Text] [Related]  

  • 25. [Pathogenetic basis of pharmaceutical hepatitis induced by depakine in children].
    Podymova SD; Sadovnikova IV
    Eksp Klin Gastroenterol; 2009; (8):30-5. PubMed ID: 20469676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sodium valproate -- induced skeletal myopathy.
    Kasturi L; Sawant SP
    Indian J Pediatr; 2005 Mar; 72(3):243-4. PubMed ID: 15812121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Valproic acid-induced hepatotoxicity in Alpers syndrome is associated with mitochondrial permeability transition pore opening-dependent apoptotic sensitivity in an induced pluripotent stem cell model.
    Li S; Guo J; Ying Z; Chen S; Yang L; Chen K; Long Q; Qin D; Pei D; Liu X
    Hepatology; 2015 May; 61(5):1730-9. PubMed ID: 25605636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Valproic-acid-associated pancreatitis and hepatic toxicity in children with endstage renal disease.
    Levin TL; Berdon WE; Seigle RR; Nash MA
    Pediatr Radiol; 1997 Feb; 27(2):192-3. PubMed ID: 9028861
    [No Abstract]   [Full Text] [Related]  

  • 29. Influence of valproic acid on the expression of various acyl-CoA dehydrogenases in rats.
    Kibayashi M; Nagao M; Chiba S
    Pediatr Int; 1999 Feb; 41(1):52-60. PubMed ID: 10200137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Asymptomatic hyperammonemia in children treated with valproic acid.
    Altunbaşak S; Baytok V; Tasouji M; Hergüner O; Burgut R; Kayrin L
    J Child Neurol; 1997 Oct; 12(7):461-3. PubMed ID: 9373804
    [No Abstract]   [Full Text] [Related]  

  • 31. Valproic acid-induced DRESS syndrome with acute liver failure.
    van Zoelen MA; de Graaf M; van Dijk MR; Bogte A; van Erpecum KJ; Rockmann H; Maarschalk-Ellerbroek LJ
    Neth J Med; 2012 Apr; 70(3):155. PubMed ID: 22516584
    [No Abstract]   [Full Text] [Related]  

  • 32. Cooccurrence of Two Different Genetic Diseases: A Case of Valproic Acid Hepatotoxicity in Nicolaides-Baraitser Syndrome (SMARCA2 Mutation)-Due to a POLG1-Related Effect?
    Hofmeister B; von Stülpnagel C; Berweck S; Abicht A; Kluger G; Weber P
    Neuropediatrics; 2020 Feb; 51(1):49-52. PubMed ID: 31541998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carnitine as an antidote for acute valproate toxicity in children.
    Russell S
    Curr Opin Pediatr; 2007 Apr; 19(2):206-10. PubMed ID: 17496767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intractable epilepsy.
    Shuper A; Gutman A; Mimouni M
    Lancet; 1999 Apr; 353(9160):1238. PubMed ID: 10217085
    [No Abstract]   [Full Text] [Related]  

  • 35. [Relationship between plasma concentrations of valproic acid and hepatotoxicity in patients receiving high doses].
    Ghozzi H; Hakim A; Sahnoun Z; Ben Mahmoud L; Atheymen R; Hammami S; Zeghal K
    Rev Neurol (Paris); 2011; 167(8-9):600-6. PubMed ID: 21492891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hepatotoxicity induced by valproic acid in adults. Report of 3 cases].
    Galdames D; Silva C; Aguilera L; Chesta J
    Rev Med Chil; 1993 Dec; 121(12):1432-6. PubMed ID: 8085069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of long-term valproic acid administration on the efficiency of carnitine reabsorption in humans.
    Stadler DD; Bale JF; Chenard CA; Rebouche CJ
    Metabolism; 1999 Jan; 48(1):74-9. PubMed ID: 9920148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two cases of valproic acid poisoning treated with L-carnitine.
    Chan YC; Tse ML; Lau FL
    Hum Exp Toxicol; 2007 Dec; 26(12):967-9. PubMed ID: 18375641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carnitine deficiency and hyperammonemia associated with valproic acid therapy.
    Ohtani Y; Endo F; Matsuda I
    J Pediatr; 1982 Nov; 101(5):782-5. PubMed ID: 6813444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thinking beyond the obvious: hepatotoxicity secondary to idiosyncratic depakote toxicity.
    Chaudrey KH; Naser TB; Steinberg A; Avashia KD; Nouri-Kolouri M; Asadi S; Irshad Khan SI; Ihsan M
    Am J Ther; 2012 Nov; 19(6):403-6. PubMed ID: 21248613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.